Authors:
Campagne, G
Garba, A
Fabre, P
Schuchat, A
Ryall, R
Boulanger, D
Bybel, M
Carlone, G
Briantais, P
Ivanoff, B
Xerri, B
Chippaux, JP
Citation: G. Campagne et al., Safety and immunogenicity of three doses of a Neisseria meningitidis A+C diphtheria conjugate vaccine in infants from Niger, PEDIAT INF, 19(2), 2000, pp. 144-150
Authors:
Van Herck, K
Beutels, P
Van Damme, P
Beutels, M
Van den Dries, J
Briantais, P
Vidor, E
Citation: K. Van Herck et al., Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines, J MED VIROL, 60(1), 2000, pp. 1-7
Authors:
Dagan, R
Greenberg, D
Goldenbertg-Gehtman, P
Vidor, E
Briantais, P
Pinsk, V
Athias, O
Dumas, R
Citation: R. Dagan et al., Safety and immunogenicity of a new formulation of an inactivated hepatitisA vaccine, VACCINE, 17(15-16), 1999, pp. 1919-1925
Authors:
Lang, J
Cetre, JC
Picot, N
Lanta, M
Briantais, P
Vital, S
Le Mener, V
Lutsch, C
Rotivel, Y
Citation: J. Lang et al., Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV), BIOLOGICALS, 26(4), 1998, pp. 299-308